| Biomarker ID | 2014 |
| PMID | 22589488 |
| Year | 2012 |
| Biomarker | Methylation status of POU3F3 |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Methylated in systemic Recurrence |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Systemic recurrence vs. local recurrence |
| Type of Biomarker | Prognostic |
| Cohort | Systemic recurrence (n = 36) versus local recurrence (n = 44) |
| Senstivity | Training: 91.3 (71.9–98.9); validation: 65.5 (40.7–84.6) |
| Specificity | Training: 75.2 (57.8–87.8); validation: 70.7 (45.7–88.1) |
| AUC | Training: 0.865; validation: 70 |
| Accuracy | NA |
| Level Of Significance | <0.0001 |
| Method Used | Pyrosequencing |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | POU3F3 |